1	Prognostic	Prognostic	B-NP	JJ	O	2	NMOD	0
2	value	value	I-NP	NN	O	0	ROOT	0
3	of	of	B-PP	IN	O	2	NMOD	0
4	angiogenesis	angiogenesis	B-NP	NN	O	3	PMOD	3	angiogenesis
5	in	in	B-PP	IN	O	2	NMOD	0
6	operable	operable	B-NP	JJ	O	10	NMOD	0
7	non-small	non-small	I-NP	JJ	O	10	NMOD	0
8	cell	cell	I-NP	NN	O	10	NMOD	0
9	lung	lung	I-NP	NN	O	10	NMOD	0
10	cancer	cancer	I-NP	NN	O	5	PMOD	0
11	.	.	O	.	O	2	P	0

1	Tumour	Tumour	B-NP	NN	O	2	NMOD	0
2	angiogenesis	angiogenesis	I-NP	NN	O	3	SUB	3	angiogenesis
3	is	be	B-VP	VBZ	O	0	ROOT	0
4	an	an	B-NP	DT	O	6	NMOD	0
5	important	important	I-NP	JJ	O	6	NMOD	0
6	factor	factor	I-NP	NN	O	3	PRD	0
7	for	for	B-PP	IN	O	6	NMOD	0
8	tumour	tumour	B-NP	NN	O	11	NMOD	0
9	growth	growth	I-NP	NN	O	8	NMOD	4	growth
10	and	and	I-NP	CC	O	8	NMOD	0
11	metastasis	metastasis	I-NP	NN	O	7	PMOD	14	metastasis
12	.	.	O	.	O	3	P	0

1	Although	Although	B-SBAR	IN	O	24	VMOD	0
2	some	some	B-NP	DT	O	4	NMOD	0
3	recent	recent	I-NP	JJ	O	4	NMOD	0
4	reports	report	I-NP	NNS	O	5	SUB	0
5	suggest	suggest	B-VP	VBP	O	1	SBAR	0
6	that	that	B-SBAR	IN	O	5	VMOD	0
7	microvessel	microvessel	B-NP	NN	O	8	NMOD	0
8	counts	count	I-NP	NNS	O	14	SUB	0
9	in	in	B-PP	IN	O	8	NMOD	0
10	non-small	non-small	B-NP	JJ	O	13	NMOD	0
11	cell	cell	I-NP	NN	O	13	NMOD	0
12	lung	lung	I-NP	NN	O	13	NMOD	0
13	cancer	cancer	I-NP	NN	O	9	PMOD	0
14	are	be	B-VP	VBP	O	6	SBAR	0
15	related	relate	I-VP	VBN	O	14	VC	0
16	to	to	B-PP	TO	O	15	VMOD	0
17	a	a	B-NP	DT	O	20	NMOD	0
18	poor	poor	I-NP	JJ	O	20	NMOD	0
19	disease	disease	I-NP	NN	O	20	NMOD	0
20	outcome	outcome	I-NP	NN	O	16	PMOD	0
21	,	,	O	,	O	24	P	0
22	the	the	B-NP	DT	O	23	NMOD	0
23	results	result	I-NP	NNS	O	24	SUB	0
24	were	be	B-VP	VBD	O	0	ROOT	0
25	not	not	O	RB	O	24	VMOD	0
26	conclusive	conclusive	B-ADJP	JJ	O	24	PRD	0
27	and	and	O	CC	O	24	VMOD	0
28	were	be	B-VP	VBD	O	24	VMOD	0
29	not	not	I-VP	RB	O	28	VMOD	0
30	compared	compare	I-VP	VBN	O	28	VC	0
31	with	with	B-PP	IN	O	30	VMOD	0
32	other	other	B-NP	JJ	O	31	PMOD	0
33	molecular	molecular	I-NP	JJ	B-protein	35	NMOD	0
34	prognostic	prognostic	I-NP	JJ	I-protein	35	NMOD	0
35	markers	marker	I-NP	NNS	I-protein	32	NMOD	0
36	.	.	O	.	O	24	P	0

1	In	In	B-PP	IN	O	9	VMOD	0
2	the	the	B-NP	DT	O	4	NMOD	0
3	present	present	I-NP	JJ	O	4	NMOD	0
4	study	study	I-NP	NN	O	1	PMOD	0
5	,	,	O	,	O	9	P	0
6	the	the	B-NP	DT	O	8	NMOD	0
7	vascular	vascular	I-NP	JJ	O	8	NMOD	0
8	grade	grade	I-NP	NN	O	9	SUB	0
9	was	be	B-VP	VBD	O	0	ROOT	0
10	assessed	assess	I-VP	VBN	O	9	VC	0
11	in	in	B-PP	IN	O	10	VMOD	0
12	107	107	B-NP	CD	O	16	NMOD	0
13	(	(	O	(	O	16	NMOD	0
14	T1	T1	B-NP	NN	B-DNA	16	NMOD	0
15	,	,	O	,	O	16	P	0
16	2-N0	2-N0	B-NP	NN	O	11	PMOD	0
17	,	,	O	,	O	9	P	0
18	1	1	B-LST	LS	O	24	NMOD	0
19	)	)	O	)	O	18	DEP	0
20	operable	operable	B-NP	JJ	O	24	NMOD	0
21	non-small	non-small	I-NP	JJ	O	24	NMOD	0
22	cell	cell	I-NP	NN	O	24	NMOD	0
23	lung	lung	I-NP	NN	O	24	NMOD	0
24	carcinomas	carcinoma	I-NP	NNS	O	9	VMOD	0
25	,	,	O	,	O	24	P	0
26	using	use	B-VP	VBG	O	24	NMOD	0
27	the	the	B-NP	DT	O	30	NMOD	0
28	JC70	JC70	I-NP	NN	B-protein	30	NMOD	0
29	monoclonal	monoclonal	I-NP	JJ	I-protein	30	NMOD	0
30	antibody	antibody	I-NP	NN	I-protein	26	OBJ	0
31	to	to	B-PP	TO	O	26	VMOD	0
32	CD31	CD31	B-NP	NN	B-protein	31	PMOD	0
33	.	.	O	.	O	9	P	0

1	Three	Three	B-NP	CD	O	3	NMOD	0
2	vascular	vascular	I-NP	JJ	O	3	NMOD	0
3	grades	grade	I-NP	NNS	O	4	SUB	0
4	were	be	B-VP	VBD	O	0	ROOT	0
5	defined	define	I-VP	VBN	O	4	VC	0
6	with	with	B-PP	IN	O	5	VMOD	0
7	appraisal	appraisal	B-NP	NN	O	6	PMOD	0
8	by	by	B-PP	IN	O	5	VMOD	0
9	eye	eye	B-NP	NN	O	8	PMOD	0
10	and	and	B-PP	CC	O	8	PMOD	0
11	by	by	B-PP	IN	O	8	PMOD	0
12	Chalkley	Chalkley	B-NP	NNP	O	13	NMOD	0
13	counting	counting	I-NP	NN	O	11	PMOD	0
14	:	:	O	:	O	4	P	0
15	high	high	B-ADJP	JJ	O	4	PRD	0
16	(	(	O	(	O	20	DEP	0
17	Chalkley	Chalkley	B-NP	NNP	O	18	NMOD	0
18	score	score	I-NP	NN	O	20	DEP	0
19	7-12	7-12	I-NP	CD	O	18	NMOD	0
20	)	)	O	)	O	22	NMOD	0
21	,	,	O	,	O	22	P	0
22	medium	medium	B-NP	NN	O	4	VMOD	0
23	(	(	O	(	O	25	DEP	0
24	5-6	5-6	B-NP	CD	O	25	DEP	0
25	)	)	O	)	O	22	NMOD	0
26	,	,	O	,	O	22	P	0
27	and	and	O	CC	O	26	PMOD	0
28	low	low	B-ADJP	JJ	O	27	PRD	0
29	(	(	O	(	O	31	DEP	0
30	2-4	2-4	B-NP	CD	O	31	DEP	0
31	)	)	O	)	O	28	AMOD	0
32	.	.	O	.	O	4	P	0

1	There	There	B-NP	EX	O	2	SUB	0
2	was	be	B-VP	VBD	O	0	ROOT	0
3	a	a	B-NP	DT	O	5	NMOD	0
4	significant	significant	I-NP	JJ	O	5	NMOD	0
5	correlation	correlation	I-NP	NN	O	2	PRD	0
6	between	between	B-PP	IN	O	2	VMOD	0
7	eye	eye	B-NP	NN	O	8	NMOD	0
8	appraisal	appraisal	I-NP	NN	O	11	NMOD	0
9	and	and	O	CC	O	11	NMOD	0
10	Chalkley	Chalkley	B-NP	NNP	O	11	NMOD	0
11	counting	counting	I-NP	NN	O	6	PMOD	0
12	(	(	O	(	O	17	DEP	0
13	P	P	B-NP	NN	O	17	DEP	0
14	less	less	B-ADJP	JJR	O	13	NMOD	0
15	than	than	B-PP	IN	O	14	AMOD	0
16	0.0001	0.0001	B-NP	CD	O	15	PMOD	0
17	)	)	O	)	O	11	NMOD	0
18	.	.	O	.	O	2	P	0

1	Vascular	Vascular	B-NP	JJ	O	2	NMOD	0
2	grade	grade	I-NP	NN	O	3	SUB	0
3	was	be	B-VP	VBD	O	0	ROOT	0
4	not	not	O	RB	O	3	VMOD	0
5	related	related	B-ADJP	JJ	O	3	PRD	0
6	to	to	B-PP	TO	O	5	AMOD	0
7	histology	histology	B-NP	NN	O	21	NMOD	0
8	,	,	O	,	O	21	P	0
9	grade	grade	B-NP	NN	O	21	NMOD	0
10	,	,	O	,	O	21	P	0
11	proliferation	proliferation	B-NP	NN	O	12	NMOD	0
12	index	index	I-NP	NN	O	21	NMOD	0
13	(	(	O	(	O	15	DEP	0
14	Ki67	Ki67	B-NP	NN	B-protein	15	DEP	0
15	)	)	O	)	O	12	NMOD	0
16	,	,	O	,	O	21	P	0
17	or	or	O	CC	O	21	NMOD	0
18	EGFR	EGFR	B-NP	NN	B-protein	21	NMOD	0
19	or	or	O	CC	O	21	NMOD	0
20	p53	p53	B-NP	NN	B-protein	21	NMOD	0
21	expression	expression	I-NP	NN	O	6	PMOD	9	expression
22	.	.	O	.	O	3	P	0

1	Tumours	Tumour	B-NP	NNS	O	5	SUB	0
2	from	from	B-PP	IN	O	1	NMOD	0
3	younger	young	B-NP	JJR	O	4	NMOD	0
4	patients	patient	I-NP	NNS	O	2	PMOD	0
5	had	have	B-VP	VBD	O	0	ROOT	0
6	a	a	B-NP	DT	O	8	NMOD	0
7	higher	high	I-NP	JJR	O	8	NMOD	0
8	grade	grade	I-NP	NN	O	5	OBJ	0
9	of	of	B-PP	IN	O	8	NMOD	0
10	angiogenesis	angiogenesis	B-NP	NN	O	9	PMOD	3	angiogenesis
11	(	(	O	(	O	15	DEP	0
12	P	P	B-NP	NN	O	14	SUB	0
13	=	=	B-VP	SYM	O	14	VMOD	0
14	0.05	0.05	B-NP	CD	O	15	DEP	0
15	)	)	O	)	O	5	VMOD	0
16	.	.	O	.	O	5	P	0

1	Apart	Apart	B-ADVP	RB	O	13	VMOD	0
2	from	from	B-PP	IN	O	1	AMOD	0
3	the	the	B-NP	DT	O	5	NMOD	0
4	vascular	vascular	I-NP	JJ	O	5	NMOD	0
5	grade	grade	I-NP	NN	O	2	PMOD	0
6	,	,	O	,	O	13	P	0
7	none	none	B-NP	NN	O	13	SUB	0
8	of	of	B-PP	IN	O	7	NMOD	0
9	the	the	B-NP	DT	O	11	NMOD	0
10	other	other	I-NP	JJ	O	11	NMOD	0
11	factors	factor	I-NP	NNS	O	8	PMOD	0
12	examined	examine	B-VP	VBN	O	11	NMOD	0
13	was	be	B-VP	VBD	O	0	ROOT	0
14	statistically	statistically	I-VP	RB	O	13	VMOD	0
15	related	relate	I-VP	VBN	O	13	PRD	0
16	to	to	B-PP	TO	O	15	AMOD	0
17	lymph	lymph	B-NP	NN	O	19	NMOD	0
18	node	node	I-NP	NN	O	19	NMOD	0
19	metastasis	metastasis	I-NP	NN	O	16	PMOD	0
20	(	(	O	(	O	25	DEP	0
21	P	P	B-NP	NN	O	25	DEP	0
22	less	less	B-ADJP	JJR	O	21	NMOD	0
23	than	than	B-PP	IN	O	22	AMOD	0
24	0.0001	0.0001	B-NP	CD	O	23	PMOD	0
25	)	)	O	)	O	19	NMOD	0
26	.	.	O	.	O	13	P	0

1	A	A	B-NP	DT	O	3	NMOD	0
2	univariate	univariate	I-NP	JJ	O	3	NMOD	0
3	analysis	analysis	I-NP	NN	O	6	SUB	0
4	of	of	B-PP	IN	O	3	NMOD	0
5	survival	survival	B-NP	NN	O	4	PMOD	0
6	showed	show	B-VP	VBD	O	0	ROOT	0
7	that	that	B-SBAR	IN	O	6	VMOD	0
8	vascular	vascular	B-NP	JJ	O	9	NMOD	0
9	grade	grade	I-NP	NN	O	10	SUB	0
10	was	be	B-VP	VBD	O	7	SBAR	0
11	the	the	B-NP	DT	O	15	NMOD	0
12	most	most	I-NP	RBS	O	13	AMOD	0
13	significant	significant	I-NP	JJ	O	15	NMOD	0
14	prognostic	prognostic	I-NP	JJ	O	15	NMOD	0
15	factor	factor	I-NP	NN	O	10	PRD	0
16	(	(	O	(	O	20	DEP	0
17	P	P	B-NP	NN	O	20	DEP	0
18	=	=	B-VP	SYM	O	17	NMOD	0
19	0.0004	0.0004	B-NP	CD	O	18	AMOD	0
20	)	)	O	)	O	15	NMOD	0
21	,	,	O	,	O	10	P	0
22	followed	follow	B-VP	VBN	O	10	VMOD	0
23	by	by	B-PP	IN	O	22	VMOD	0
24	N-stage	N-stage	B-NP	NN	O	23	PMOD	0
25	(	(	O	(	O	29	DEP	0
26	P	P	B-NP	NN	O	28	SUB	0
27	=	=	B-VP	SYM	O	28	VMOD	0
28	0.001	0.001	B-NP	CD	O	29	DEP	0
29	)	)	O	)	O	22	VMOD	0
30	.	.	O	.	O	6	P	0

1	In	In	B-PP	IN	O	10	VMOD	0
2	a	a	B-NP	DT	O	4	NMOD	0
3	multivariate	multivariate	I-NP	JJ	O	4	NMOD	0
4	analysis	analysis	I-NP	NN	O	1	PMOD	0
5	,	,	O	,	O	10	P	0
6	N-stage	N-stage	B-NP	NN	O	9	NMOD	0
7	and	and	O	CC	O	9	NMOD	0
8	vascular	vascular	B-NP	JJ	O	9	NMOD	0
9	grade	grade	I-NP	NN	O	10	SUB	0
10	were	be	B-VP	VBD	O	0	ROOT	0
11	not	not	I-VP	RB	O	10	VMOD	0
12	found	find	I-VP	VBN	O	10	VC	0
13	to	to	I-VP	TO	O	14	VMOD	0
14	be	be	I-VP	VB	O	12	VMOD	0
15	independent	independent	B-NP	JJ	O	17	NMOD	0
16	prognostic	prognostic	I-NP	JJ	O	17	NMOD	0
17	factors	factor	I-NP	NNS	O	14	PRD	0
18	,	,	O	,	O	10	P	0
19	since	since	B-SBAR	IN	O	10	VMOD	0
20	they	they	B-NP	PRP	O	21	SUB	0
21	were	be	B-VP	VBD	O	19	SBAR	0
22	strongly	strongly	I-VP	RB	O	21	VMOD	0
23	related	relate	I-VP	VBN	O	21	VC	0
24	to	to	B-PP	TO	O	23	VMOD	0
25	each	each	B-NP	DT	O	26	NMOD	0
26	other	other	I-NP	JJ	O	24	PMOD	0
27	.	.	O	.	O	10	P	0

1	Excluding	Exclude	B-PP	VBG	O	6	VMOD	0
2	N-stage	N-stage	B-NP	NN	O	5	NMOD	0
3	,	,	O	,	O	5	P	0
4	vascular	vascular	B-NP	JJ	O	5	NMOD	0
5	grade	grade	I-NP	NN	O	6	SUB	0
6	was	be	B-VP	VBD	O	0	ROOT	0
7	the	the	B-NP	DT	O	11	NMOD	0
8	only	only	I-NP	JJ	O	11	NMOD	0
9	independent	independent	I-NP	JJ	O	11	NMOD	0
10	prognostic	prognostic	I-NP	JJ	O	11	NMOD	0
11	factor	factor	I-NP	NN	O	6	PRD	0
12	(	(	O	(	O	16	DEP	0
13	P	P	B-NP	NN	O	15	SUB	0
14	=	=	B-VP	SYM	O	15	VMOD	0
15	0.007	0.007	B-NP	CD	O	16	DEP	0
16	)	)	O	)	O	11	NMOD	0
17	.	.	O	.	O	6	P	0

1	Kaplan-Meier	Kaplan-Mei	B-NP	JJR	O	3	NMOD	0
2	survival	survival	I-NP	NN	O	3	NMOD	0
3	curves	curve	I-NP	NNS	O	4	SUB	0
4	showed	show	B-VP	VBD	O	20	VMOD	0
5	a	a	B-NP	DT	O	9	NMOD	0
6	statistically	statistically	I-NP	RB	O	7	AMOD	0
7	significant	significant	I-NP	JJ	O	8	AMOD	0
8	worse	worse	I-NP	JJR	O	9	NMOD	0
9	prognosis	prognosis	I-NP	NN	O	4	OBJ	0
10	for	for	B-PP	IN	O	9	NMOD	0
11	patients	patient	B-NP	NNS	O	10	PMOD	0
12	with	with	B-PP	IN	O	11	NMOD	0
13	high	high	B-NP	JJ	O	15	NMOD	0
14	vascular	vascular	I-NP	JJ	O	15	NMOD	0
15	grade	grade	I-NP	NN	O	12	PMOD	0
16	,	,	O	,	O	20	P	0
17	but	but	O	CC	O	20	VMOD	0
18	no	no	B-NP	DT	O	19	NMOD	0
19	difference	difference	I-NP	NN	O	20	SUB	0
20	was	be	B-VP	VBD	O	0	ROOT	0
21	observed	observe	I-VP	VBN	O	20	VC	0
22	between	between	B-PP	IN	O	21	VMOD	0
23	low	low	B-NP	JJ	O	25	AMOD	0
24	and	and	I-NP	CC	O	25	AMOD	0
25	medium	medium	I-NP	JJ	O	27	NMOD	0
26	vascular	vascular	I-NP	JJ	O	27	NMOD	0
27	grade	grade	I-NP	NN	O	22	PMOD	0
28	.	.	O	.	O	20	P	0

1	These	These	B-NP	DT	O	2	NMOD	0
2	data	datum	I-NP	NNS	O	3	SUB	0
3	suggest	suggest	B-VP	VBP	O	0	ROOT	0
4	that	that	B-SBAR	IN	O	3	VMOD	0
5	angiogenesis	angiogenesis	B-NP	NN	O	12	SUB	3	angiogenesis
6	in	in	B-PP	IN	O	5	NMOD	0
7	operable	operable	B-NP	JJ	O	11	NMOD	0
8	non-small	non-small	I-NP	JJ	O	11	NMOD	0
9	cell	cell	I-NP	NN	O	11	NMOD	0
10	lung	lung	I-NP	NN	O	11	NMOD	0
11	cancer	cancer	I-NP	NN	O	6	PMOD	0
12	is	be	B-VP	VBZ	O	4	SBAR	0
13	a	a	B-NP	DT	O	16	NMOD	0
14	major	major	I-NP	JJ	B-protein	16	NMOD	0
15	prognostic	prognostic	I-NP	JJ	I-protein	16	NMOD	0
16	factor	factor	I-NP	NN	I-protein	12	PRD	0
17	for	for	B-PP	IN	O	16	NMOD	0
18	survival	survival	B-NP	NN	O	17	PMOD	0
19	and	and	O	CC	O	12	VMOD	0
20	,	,	O	,	O	12	P	0
21	among	among	B-PP	IN	O	12	VMOD	0
22	the	the	B-NP	DT	O	23	NMOD	0
23	parameters	parameter	I-NP	NNS	O	21	PMOD	0
24	tested	test	B-VP	VBN	O	23	NMOD	0
25	,	,	O	,	O	12	P	0
26	is	be	B-VP	VBZ	O	12	VMOD	0
27	the	the	B-NP	DT	O	29	NMOD	0
28	only	only	I-NP	JJ	O	29	NMOD	0
29	factor	factor	I-NP	NN	O	26	PRD	0
30	related	related	B-ADJP	JJ	O	29	NMOD	0
31	to	to	B-PP	TO	O	30	AMOD	0
32	cancer	cancer	B-NP	NN	O	34	NMOD	0
33	cell	cell	I-NP	NN	O	34	NMOD	0
34	migration	migration	I-NP	NN	O	31	PMOD	14	migration
35	to	to	B-PP	TO	O	34	NMOD	0
36	lymph	lymph	B-NP	NN	O	37	NMOD	0
37	nodes	node	I-NP	NNS	O	35	PMOD	0
38	.	.	O	.	O	3	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	integration	integration	I-NP	NN	O	14	SUB	0
3	of	of	B-PP	IN	O	2	NMOD	0
4	vascular	vascular	B-NP	JJ	O	5	NMOD	0
5	grading	grading	I-NP	NN	O	3	PMOD	0
6	in	in	B-PP	IN	O	2	NMOD	0
7	clinical	clinical	B-NP	JJ	O	8	NMOD	0
8	trials	trial	I-NP	NNS	O	6	PMOD	0
9	on	on	B-PP	IN	O	2	NMOD	0
10	adjuvant	adjuvant	B-NP	JJ	O	11	NMOD	0
11	chemotherapy	chemotherapy	I-NP	NN	O	13	NMOD	19	chemotherapy
12	and/or	and/or	I-NP	CC	O	13	NMOD	0
13	radiotherapy	radiotherapy	I-NP	NN	O	9	PMOD	19	radiotherapy
14	could	could	B-VP	MD	O	0	ROOT	0
15	substantially	substantially	I-VP	RB	O	14	VMOD	0
16	contribute	contribute	I-VP	VB	O	14	VC	0
17	in	in	B-PP	IN	O	16	VMOD	0
18	defining	define	B-VP	VBG	O	19	NMOD	0
19	groups	group	B-NP	NNS	O	17	PMOD	0
20	of	of	B-PP	IN	O	19	NMOD	0
21	operable	operable	B-NP	JJ	O	22	NMOD	0
22	patients	patient	I-NP	NNS	O	20	PMOD	0
23	who	who	B-NP	WP	O	22	NMOD	0
24	might	might	B-VP	MD	O	23	SBAR	0
25	benefit	benefit	I-VP	VB	O	24	VC	0
26	from	from	B-PP	IN	O	25	VMOD	0
27	cytotoxic	cytotoxic	B-NP	JJ	O	28	NMOD	0
28	treatment	treatment	I-NP	NN	O	26	PMOD	0
29	.	.	O	.	O	14	P	0

